Nasdaq:US$13.55 (+0.20) | HKEX:HK$20.80 (+0.08) | AIM:£1.99 (-0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF